R
RANI
Rani Therapeutics Holdings, Inc.
0.81
0.07+9.61%After Hours: 0.8014 -0.00 -0.50%19:58 04/01 EDT
OPEN/PREV CLOSE0.7410/0.7348
TODAY RANGE0.6800-0.8054
VOL2.33M
MARKET CAP99.62M
52 WEEK RANGE0.3870-3.870
AVG VOL (3M)1.17M
% TURNOVER1.88%
TURNOVER--
P/E (TTM)-1.7950
% RANGE17.07%
EPS(TTM)-0.4487
P/E(FORWARD)-3.3558
P/B2.966
BVPS0.2715
DIVIDEND--
P/S60.10
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP74.06M
SHARES OUTSTANDING123.69M
NEXT EARNINGS05/11-05/17
FREE FLOAT91.96M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·6d ago
Rani Therapeutics' net loss narrows in Q4 as costs fall
Seeking Alpha·6d ago
Rani Therapeutics GAAP EPS of -$0.07 in-line, revenue of $1.46M misses by $3.54M
Dow Jones·6d ago
*Rani Therapeutics Sees Funding Sufficient Into 4Q27 >RANI
Dow Jones·6d ago
*Rani Therapeutics 4Q Loss/Shr 7c >RANI
Dow Jones·6d ago
*Rani Therapeutics 4Q Rev $1.5M >RANI
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.